MedTrace Logo

Quality of Life Study in Patients With Cancer Breakthrough Pain Treated in Palliative Care Units

NCT02840500 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 101

Last updated 2018-03-05

No results posted yet for this study

Summary

Patients treated in Palliative Care Units are potentially fragile patients, especially in our case, which are cancer patients. The management of these patients is usually done from experience, because these patients rarely meet criteria for clinical trials, as their inclusion could affect results obtained in the trial.

There is insufficient clinical information on the quality of life of cancer patients with breakthrough pain treated in palliative care units according to routine clinical practice. For this reason we consider it is appropriate to prospectively evaluate the quality of life of cancer patients with cancer breakthrough pain treated in palliative care units as well as the characteristics of these patients.

This post-authorization observational study will assess the quality of life of patients with breakthrough cancer pain treated in Palliative Care Units in Spanish hospitals.

Conditions

  • Breakthrough Pain

Interventions

OTHER

No intervention

No intervention

Sponsors & Collaborators

  • Angelini Farmacéutica

    lead INDUSTRY

Principal Investigators

  • Albert Tuca, MD · Hospital Clinic de Barcelona, Palliative Care Unit

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-06-27
Primary Completion
2017-12-31
Completion
2018-03-31

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02840500 on ClinicalTrials.gov